JUN dependency in distinct early and late BRAF inhibition adaptation states of melanoma
Open Access
- 6 September 2016
- journal article
- research article
- Published by Springer Nature in Cell Discovery
- Vol. 2 (1) , 16028
Abstract
A prominent mechanism of acquired resistance to BRAF inhibitors in BRAFV600-mutant melanoma is associated with the upregulation of receptor tyrosine kinases. Evidences suggested that this resistance mechanism is part of a more complex cellular adaptation process. Using an integrative strategy, we found this mechanism to invoke extensive transcriptomic, (phospho-) proteomic and phenotypic alterations that accompany a cellular transition to a de-differentiated, mesenchymal and invasive state. Even short-term BRAF-inhibitor exposure leads to an early adaptive, differentiation state change—characterized by a slow-cycling, persistent state. The early persistent state is distinct from the late proliferative, resistant state. However, both differentiation states share common signaling alterations including JUN upregulation. Motivated by the similarities, we found that co-targeting of BRAF and JUN is synergistic in killing fully resistant cells; and when used up-front, co-targeting substantially impairs the formation of the persistent subpopulation. We confirmed that JUN upregulation is a common response to BRAF inhibitor treatment in clinically treated patient tumors. Our findings demonstrate that events shared between early- and late-adaptation states provide candidate up-front co-treatment targets.Keywords
This publication has 94 references indexed in Scilit:
- Widespread potential for growth-factor-driven resistance to anticancer kinase inhibitorsNature, 2012
- Tumour micro-environment elicits innate resistance to RAF inhibitors through HGF secretionNature, 2012
- Discovery of Potent and Selective Covalent Inhibitors of JNKChemistry & Biology, 2012
- Acquired Resistance to BRAF Inhibitors Mediated by a RAF Kinase Switch in Melanoma Can Be Overcome by Cotargeting MEK and IGF-1R/PI3KCancer Cell, 2010
- Epithelial-Mesenchymal Transition-Derived Cells Exhibit Multilineage Differentiation Potential Similar to Mesenchymal Stem CellsStem Cells, 2010
- Activation of Aortic Endothelial Cells by Oxidized Phospholipids: A Phosphoproteomic AnalysisJournal of Proteome Research, 2010
- Epithelial-Mesenchymal Transitions in Development and DiseaseCell, 2009
- Bypassing cellular EGF receptor dependence through epithelial-to-mesenchymal-like transitionsClinical & Experimental Metastasis, 2008
- Increased expression of stem cell markers in malignant melanomaLaboratory Investigation, 2007
- Mutations of the BRAF gene in human cancerNature, 2002